Dr. Vickers is the president and CEO of Memorial Sloan Kettering Cancer Center, a role he has held since September 2022. An internationally recognized pancreatic cancer surgeon and researcher, Dr. Vickers has made significant contributions to health disparities research and is a member of the National Academy of Medicine. Prior to leading Memorial Sloan Kettering Cancer Center, he held several academic leadership positions, including senior vice president of medicine and dean at the University of Alabama at Birmingham, where he also led the UAB Health System and the UAB/Ascension St. Vincent’s Alliance. Dr. Vickers played a key role in the development of Minnelide, an injectable cancer drug, which entered phase 2 trials in 2019. Throughout his career, he has also held prominent positions in several medical societies, including serving as past president of the Beverly, Mass.-based American Surgical Association.
